期刊文献+

mdr1反义寡核苷酸增强多药耐药肝癌细胞HepG2/ADM化疗敏感性的实验研究 被引量:1

Experimental research of chemotherapeutic sensitization for multidrug resistance hepatocellular carcinoma cell HepG2/ADM enhanced by mdr1antisense oligonucleotides
下载PDF
导出
摘要 目的探讨在体外实验条件下mdr1反义寡核苷酸对多药耐药肝癌细胞株化疗敏感性的影响。方法以肝癌细胞Hep G2/ADM为研究对象,设立mdr1反义寡核苷酸组和空白试剂组作对照,利用脂质体包载肿瘤耐药基因mdr1的反义寡核苷酸进行细胞转染,通过反转录聚合酶链反应(RT-PCR)、免疫印迹实验(Western blotting)分别检测mdr1基因m RNA和P-gp蛋白表达,通过MTT实验检测细胞转染前后对阿霉素(ADM)、顺铂(DDP)和5-氟尿嘧啶(5-FU)的化疗敏感性。结果 Hep G2/AMD肝癌细胞经反义寡核苷酸处理后,mdr1m RNA、P-gp蛋白表达水平均明显降低,对ADM、DDP和5-FU的化疗敏感性明显增强。结论反义寡核苷酸能在体外有效增加肝癌细胞Hep G2/ADM对化疗药物的敏感性。 Objective To study the effect of mdr1 genes antisense oligonucleotides in vitro on chemotherapeutic sensiti-zation for multidrug resistance hepatocellular carcinoma cell lines. Methods The hepatocellular carcinoma cell HepG2/ADM was taken as research object,and mdr1 genes antisense oligonucleotides group and blank control group were established. The cell transfection was conducted by antisense oligonucleotides of liposome entrapment drug resistance gene mdr1. The protein expres-sions of mRNA and P-gp of mdr1 gene were detected by reverse transcription-polymerase chain reaction(RT-PCR) and Western blotting respectively,while the chemotherapeutic sensitization to ADM,DDP and 5-FU before and after cell transfection by MTT. Results After transfecting by antisense oligonucleotides,the protein expression levels of mdr1,mRNA and P-gp in hepatocellu-lar carcinoma cell HepG2/ADM decreased obviously,and the chemotherapeutic sensitization to ADM,DDP and 5-FU increased prominently. Conclusion The antisense oligonucleotides can improve the sensitization of HepG2/ADM to chemotherapy drugs in vitro.
出处 《现代医药卫生》 2014年第22期3363-3364,3367,共3页 Journal of Modern Medicine & Health
基金 国家自然科学基金(81171365) 重庆市自然科学基金(2010BB5358)
关键词 肝细胞 肝肿瘤 RNA 信使 寡核苷酸 反义 抗药性 多药 药物耐受性 Carcinoma,hepatocelluar Liver neoplasms RNA,messenger Oligonucleotids,antisense Drug resistance,multiple Drug tolerance sensitive test
  • 相关文献

参考文献15

  • 1Zheng LH,Bao YL,Wu Y,et al. Cantharidin reveres muhidrug resistance of human hepatoma HepG2/ADM cells via down-regu- lation of P-glycoprotein expression [J]. Cancer Lett,2008,272 (1) : 102-109.
  • 2. Shen YC,Hsu C,Cheng AL. Molecular targeted therapy for ad- vanced hepatocellular carcinoma:current status and future per- spectives[J]. J Gastroenterol, 2010,45 (8) : 794-807.
  • 3张慧,符立梧.多药耐药相关蛋白及其在肿瘤耐药中的作用[J].药学学报,2011,46(5):479-486. 被引量:31
  • 4Sun BT,Zheng LH ,Ban YL,et al. Reversal effect of Dioscin on muhidrug resistance in human hepatoma HepG2/adriamycin cells[J]. Eur J Pharmacol, 2011,654(2) : 129-134.
  • 5Doaa M ,Ynussef,Tarek A. Attia,Amal S. E1-Shal,et al. Multi- drug resistance-1 gene polymorphisms in nephrotie syndrome: Impact on susceptibility and response to steroids[J]. Gene, 2013, 530(2) : 201-207.
  • 6孙静,孔冉,赵修世,王琳,刘传亮,李文通.RNAi逆转淋巴瘤LRP和P-gp介导的多药耐药研究[J].现代医药卫生,2012,28(4):481-482. 被引量:2
  • 7尹宝慧,贾秀红,李建厂.RNA干扰抑制HOXA7表达能逆转白血病U937细胞多药耐药[J].肿瘤,2013,33(7):585-591. 被引量:4
  • 8Wu F, Shao ZY, Zhai B J, et al. Ultrasound reverses multidrug resistance in human cancer cells by altering gene expression of ABC transporter proteins and Bax protein [J]. Ultrasound Med Biol, 2011,37(1) :151-159.
  • 9梅梅,张翼,任金红,谢丹,贾雨霏,扈金萍,李燕,戴均贵,陈晓光.新型紫杉烷化合物NPB304及其协同维拉帕米逆转耐药的研究[J].药学学报,2014,49(9):1279-1288. 被引量:9
  • 10Mazzanti R, Platini F, Bottini C, et al. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line [J]. Biochem Pharmacol, 2009,78 ( 1 ) : 21-32.

二级参考文献18

共引文献42

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部